Neutralny
Pfizer's stock remains stable at $25.01 amid recent developments.
Ten briefing nie jest jeszcze dostępny w tym języku — wyświetlana jest wersja angielska.
In the past 24 hours, Pfizer's stock price has remained relatively unchanged at $25.01. Recent developments include a significant increase in call option activity and a notable sale of shares by PNC Financial Services Group Inc. However, no major news has emerged to significantly impact the stock's performance.
Kluczowe punkty
- Pfizer's stock price remains stable at $25.01, with no significant changes in the past 24 hours.
- PNC Financial Services Group Inc. sold 220,938 shares of Pfizer, reducing its stake by 3.1%.
- Investors purchased a high volume of call options on Pfizer, with 200,046 contracts traded, 76% above the average volume.
- Cantor Fitzgerald reiterated a Neutral rating on Pfizer stock following a trial miss.
Źródła
Wygenerowane przez AI na podstawie publicznych źródeł wiadomości. To nie jest porada finansowa.
